Bevacizumab Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Bevacizumab Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Bevacizumab Intravenous-Insulin degludec and liraglutide
- Bevacizumab Intravenous-Insulin degludec and liraglutide Subcutaneous
- Bevacizumab Intravenous-Insulin degludec Subcutaneous
- Bevacizumab Intravenous-Insulin detemir
- Bevacizumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Bevacizumab-awwb
- Insulin Degludec (U-100) Vials-Bevacizumab-awwb Intravenous
- Insulin Degludec (U-100) Vials-Bevespi Aerosphere
- Insulin Degludec (U-100) Vials-Bevyxxa
- Insulin Degludec (U-100) Vials-Bexarotene
- Insulin Degludec (U-100) Vials-Bexarotene (Systemic)